$1.35
0.03 (+2.27%)
ACADIA Pharmaceuticals, Inc. (ACAD)
CAPS Rating:
The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

RSS Headlines
Fool UK